生物活性
Sorafenib Tosylate (Nexavar)是几种酪氨酸蛋白激酶(VEGFR和PDGFR)和RAF/MEK/ERK级联抑制剂的新型小分子抑制剂,Raf-1,wt BRAF和V599E突变型BRAF的IC50为6、22、38 nM。
Targets
Target | Value |
Raf-1 | IC50: 6nM |
VEGFR2/Flk1 | IC50: 15nM |
B-Raf | IC50: 22nM |
B-Raf(V599E) | IC50: 38nM |
PDGFRβ | IC50: 57nM |
mPDGFRβ | IC50: 57nM |
FLT3 | IC50: 58nM |
c-Kit | IC50: 68nM |
VEGFR2 | IC50: 90nM |
FGFR1 | IC50: 580nM |
ERK1 | IC50: >10μM |
MEK1 | IC50: >10μM |
EGFR | IC50: >10μM |
HER2 | IC50: >10μM |
IGF-1R | IC50: >10μM |
c-Met | IC50: >10μM |
PKB | IC50: >10μM |
PKA | IC50: >10μM |
CDK1/CyclinB | IC50: >10μM |
PKCα | IC50: >10μM |
PKCγ | IC50: >10μM |
Pim1 | IC50: >10μM |
化学数据
目录号 | A10001 |
作用机制 | Inhibitor (抑制剂) |
M. Wt | 637 |
Formula | C21H16ClF3N4O3.C7H8O3S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. In lyophilized form, the chemical is stable for36 months. In solution, store at -20ºC and use within3 monthsto prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles. |
CAS No. | 475207-59-1 |
Synonyms | Bay 43-9006 |
SMILES | CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
溶解度
In vitro (25°C) | DMSO | 114 mg/mL (178.95 mM) |
Water | <1 mg/mL |
Ethanol | Insoluble |
In vivo | 2% Cremophor EL, 2% N,N-dimethylacetamide | 28 mg/mL |
*<1 mg/ml means slightly soluble or insoluble. *Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
储备液配制
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
0.1 mM | 15.7 mL | 78.49 mL | 156.99 mL |
0.5 mM | 3.14 mL | 15.7 mL | 31.4 mL |
1 mM | 1.57 mL | 7.85 mL | 15.7 mL |
5 mM | 0.31 mL | 1.57 mL | 3.14 mL |
*The above data is based on the productmolecular weight 637. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.